PreCOMA AI: Sedation-Aware Early Prediction of New-Onset ICU Coma
Predicting transition to profound coma up to 12 hours ahead with explicit sedation differentiation and operational false-alert control.
New-onset coma in the intensive care unit is a life-threatening clinical event that is typically detected only after profound, irreversible neurological or systemic failure has already taken hold. Conventional bedside systems are reactive and unable to separate deliberate therapeutic sedation from pathological deterioration. PreCOMA AI transforms evolving consciousness trajectories, sedative exposures, and organ dynamics into personalized early warnings.
The Critical Surveillance Gap in ICU Neurological Decline
New-onset coma is among the most catastrophic acute developments in intensive care, associated with prolonged mechanical ventilation, secondary brain injury, and marked mortality. Current bedside systems remain reactive and siloed.
Episodic Bedside Scoring Delay
Clinical loss of consciousness is typically identified only during routine periodic assessments, hours after subclinical damage has occurred. By the time deep coma (RASS −4/−5 or GCS ≤8) is observed, opportunities for early neuroprotection are lost.
Therapeutic Sedation Overlap
ICU patients routinely receive continuous propofol, dexmedetomidine, and opioid infusions. Conventional early warning scores cannot separate deliberate clinical sedation from insidious pathological neuro-failure, generating false alarms and masking encephalopathy.
Nuisance Monitor Desensitization
Static bedside monitors fire continuously for patients already known to be sedated, triggering severe nursing and intensivist alarm fatigue. Care teams urgently require a context-gated framework that silences anticipated sedation while surfacing true neurological decline.
Absence of 12-Hour Foresight
Current intensive care practice reacts to coma only after profound loss of consciousness has already manifested. Without 12-hour predictive lead time, clinicians cannot pre-emptively order neuroimaging, pause suspect medications, or plan elective airway protection.
Four Pillars of Sedation-Aware Neurological Early Warning
A dynamic multimodal neural network pipeline combining continuous consciousness trajectories, pharmacokinetic drug dampening, and multi-center score harmonization across four disciplined pillars.
Clinical Feature & Sedation Engine
Converts raw EHR streams into standardized hourly prediction windows. Ingests serial consciousness scores, active sedative and opioid exposures (propofol, midazolam, dexmedetomidine, fentanyl), cumulative medication burden, rate slopes, and missingness indicators.
- RASS and GCS consciousness score harmonization
- Pharmacokinetic sedative cumulative exposure index
- Multi-parameter vital sign instability tracking
Compact Time-Series Transformer
Processes longitudinal temporal sequences across multi-hour horizons. Attention mechanisms learn complex dependencies between pharmacological sedation changes, invasive mechanical ventilation status, and insidious metabolic deterioration.
- Temporal self-attention across sliding observation windows
- Cross-modal fusion between labs, vitals, and sedatives
- Optimized lightweight architecture for sub-second inference
Dynamic Calibration & Risk Layer
Outputs a rigorously calibrated probability of transition from a non-comatose baseline to new-onset coma within the subsequent 12 hours. Offers clinically tunable operating thresholds balancing high sensitivity against false alert tolerance.
- Calibrated transition probabilities (AUROC 0.91)
- Unit-customizable operating points (89–94% sensitivity)
- Trajectory acceleration detection as transition approaches
Sedation Context & Alert Cooldown
Intelligent post-processing that immediately suppresses alerts for patients already comatose, downgrades planned procedural sedation states, requires persistent high-risk trajectory confirmation, and enforces refractory alert cooldown protocols.
- Automatic suppression for established comatose baseline
- Therapeutic vs. pathological sedation discriminator
- Operational false alert rate constrained to ~0.7 / day
Multi-Center Validation Across Diverse Intensive Care Cohorts
PreCOMA AI was developed, internally tested, and externally transported across diverse intensive care settings comprising extensive adult admissions with international consciousness score harmonization.
Maintained discriminatory power across diverse ICU clinical archetypes and independent multi-center cohorts.
Clinically tunable operating points tailored to unit acuity and neurocritical care workflow priorities.
Robust suppression of baseline physiological fluctuations and transient procedural sedation titrations.
Low nuisance alert rate engineered to eliminate nurse alarm desensitization across intensive care units.
Linked Cohort Scale & Multi-Center Transportability
Multi-Unit Critical Care Development Cohort
Trained and internally validated across an extensive multi-unit intensive care population, evaluating hourly transition to deep coma defined primarily by RASS −4 or −5 within 12 hours.
Independent Central European Registry
Independent external transportability assessed across diverse European ICU admissions, confirming 0.90–0.92 AUROC under harmonized RASS and GCS ≤8 consciousness endpoints.
Secondary Western European Transportability Cohort
Transportability verified across extensive academic intensive care admissions in Western Europe, confirming 0.89–0.91 AUROC stability across international critical care practice guidelines.
Deploying PreCOMA AI in Intensive Care Environments
Enabling proactive neurological decision support, early diagnostic imaging, and fatigue-free bedside monitoring.
Neurocritical Care & Secondary Brain Injury
Continuous monitoring of traumatic brain injury, ischemic stroke, and intracerebral hemorrhage patients. Early alerts trigger urgent non-contrast CT, automated pupillometry, and ICP evaluation before transtentorial herniation or irreversible brainstem compression occur.
Sepsis-Associated Encephalopathy
In severe sepsis, septic shock, and hepatic or renal failure, subclinical encephalopathy progresses silently. PreCOMA AI detects insidious consciousness decay 12 hours ahead, prompting earlier metabolic correction, ammonia evaluation, or emergent dialysis.
Targeted Sedation Weaning & SAT Guidance
By isolating true physiological deterioration from pharmacodynamic drug presence, the system supports Spontaneous Awakening Trials (SAT) and Spontaneous Breathing Trials (SBT)—identifying patients at imminent risk of coma during or after sedation pauses.
Alarm Fatigue Elimination & Prioritized Rounds
Replaces static, high-frequency consciousness alarms with a single, highly calibrated, low-burden predictive indicator (~0.7 alerts/patient-day). Enables intensivist teams during morning and night rounds to prioritize high-risk patients before acute decompensation.
Clinical Translation & Implementation Roadmap
A four-phase execution timeline moving from multi-center retrospective validation to real-time EHR streaming and clinical trials.
Multi-Center Retrospective Model Validation
International harmonization of RASS and GCS consciousness scores across diverse multi-center intensive care cohorts. Achievement of 0.91 AUROC with ~0.7 false alerts per patient-day.
Real-Time FHIR / HL7 Telemetry Integration
Engineering lightweight edge adapters capable of ingesting high-frequency consciousness scores, infusion rates, and ventilator telemetry from hospital central stations (Epic Systems, Philips IntelliVue, GE CARESCAPE) with sub-second inference.
Prospective Observational Silent Trial
Multi-bed ICU silent trial assessing real-time lead times, sedation confounding resolution, and clinician usability across tertiary neurocritical and medical-surgical ICUs without bedside alert display.
Interventional Trial & Clinical Decision Support
Randomized trial evaluating whether automated 12-hour predictive alerts combined with structured neuro-diagnostic protocols decrease time to coma reversal, reduce ICU length of stay, and improve functional patient outcomes.
Technical & Clinical Questions
Detailed answers on sedation differentiation, RASS/GCS score harmonization, and false-alarm suppression.
How does PreCOMA AI differentiate between medication sedation and true neurological coma? +
PreCOMA AI incorporates continuous pharmacodynamic exposures, including sedative infusion rates, boluses, and cumulative drug burdens (propofol, midazolam, dexmedetomidine, fentanyl). Its clinical context layer compares the patient's observed trajectory against expected pharmacokinetic drug dissipation curves, suppressing alerts when decline is fully explained by planned clinical sedation.
What defines the primary coma endpoint across international datasets? +
The primary endpoint is transition from a non-comatose baseline to a comatose state within 12 hours. In units utilizing the Richmond Agitation-Sedation Scale, this is defined as RASS −4 (deep sedation) or −5 (unresponsive). In centers utilizing the Glasgow Coma Scale, it is harmonized to GCS ≤8, ensuring seamless multi-center generalizability.
Why is a 12-hour prediction horizon clinically optimal? +
A 12-hour horizon provides clinicians with an actionable operational window. Unlike immediate crash alarms that leave only minutes to react, 12 hours allows the care team to order laboratory panels, schedule head imaging (CT/MRI), titrate suspect neurotoxic medications, reverse metabolic abnormalities, or plan airway protection before emergency intubation is required.
How is the false-alert burden constrained to ~0.7 alerts per patient-day? +
PreCOMA AI applies a multi-stage alert filter: it immediately suppresses alerts in patients who are already comatose, downgrades planned procedural sedation windows, mandates persistent high-risk predictions across consecutive prediction windows before firing, and enforces refractory cooldown intervals.
Deploy PreCOMA AI in Your Critical Care Unit
We are actively partnering with academic medical centers, intensive care networks, and clinical research teams to deploy and validate PreCOMA AI across diverse patient populations.